AHR and chronic kidney disease: Moreover, the activation of the aryl hydrocarbon receptor by other tryptophan metabolites (such as kynurenine, which also accumulates in patients with CKD and is associated with CKD complications [51] but is not modulated by AST-120) could explain (at least in part) this discrepancy.